article thumbnail

Grab acquires Singapore’s third-largest taxi operator Trans-cab 

TechCrunch: M&A

Consolidation via mergers and acquisitions is on the rise in the tech industry as tight private capital and a slow initial public offering market due to the economic downturn are impacted by growing inflations and high-interest rate headwinds.

article thumbnail

How Common are Postmerger Divestitures of Acquired Company Units?

M&A Leadership Council

Fundamentals of M&A: An Excerpt from The Art of M&A Book Series. In a follow-up study for the 10 largest mergers of 1985, the author of this book found that only a minority of the deals had ended in a divestiture even after 20 years – and most of the divestitures were partial. What kinds of divestitures are there? Recent U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings.

M&A 59
article thumbnail

What is Limited Liability Company?

Razorpay

Public Limited Company It is a type of entity defined in the Companies Act 2013 as an entity whose shares can be held by the general public. The shares can be traded on stock exchanges or subscribed through Initial Public Offering (IPO). A public limited company is formed with a minimum of 7 shareholders.

article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. Looking forward, we expect a focus on the sector by the FTC to continue, especially given that perceived high drug prices remain a bipartisan area of concern.

M&A 64